Immune Enhancement Project Report issue

Foundation

Organization Overview

First Clinical Trial
1999
NCT00002149
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (3)

amoxicillin (1 trial)

clavulanate (Augmentin) (1 trial)

pseudoephedrine (Benylin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3